Interference of colostral antibodies with response to a Bluetongue serotype 8 inactivated vaccine in lambs born from hyperimmune ewes

Vaccine

Volumn 31, Issue 15, 2013, Pages 1975-1980

  Leemans, Jérôme ^a,b   Hamers, Claude ^b   Chery, Roland ^b   Bibard, Amandine ^b   Besancon, Laure ^b   Duboeuf, Michelle ^b   Hudelet, Pascal ^b   Goutebroze, Sylvain ^b   Kirschvink, Nathalie ^a  

^a University of Namur   (Belgium)

^b Keyrus Biopharma ^*  (Belgium)

Author keywords

Bluetongue virus serotype 8; Inactivated vaccine; Lambs; Maternal antibody interference; Seroconversion; Viral challenge

Indexed keywords

INACTIVATED VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLUETONGUE; BLUETONGUE ORBIVIRUS; BLUETONGUE SEROTYPE 8; CONTROLLED STUDY; EWE; IMMUNE STATUS; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VACCINATION; VIREMIA;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLUETONGUE; BLUETONGUE VIRUS; COLOSTRUM; FEMALE; FRANCE; PREGNANCY; RNA, VIRAL; SHEEP, DOMESTIC; TIME FACTORS; VACCINATION; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 84875275018     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.02.005     Document Type: Article

References (18)

1. Schwartz-Cornil I., Mertens P.P., Contreras V., Hemati B., Pascale F., Breard E., et al. Bluetongue virus: virology, pathogenesis and immunity. Vet Res 2008, 39:46.
2. Saegerman C., Berkvens D., Mellor P.S. Bluetongue epidemiology in the European Union. Emerg Infect Dis 2008, 14:539-544.
3. Roy P., Boyce M., Noad R. Prospects for improved bluetongue vaccines. Nat Rev Microbiol 2009, 7:120-128.
4. Savini G., Maclachlan N.J., Sanchez-Vizcaino J.M., Zientara S. Vaccines against bluetongue in Europe. Comp Immunol Microbiol Infect Dis 2008, 31:101-120.
5. Dercksen D., Groot Nibbelink N., Paauwe R., Backx A., van Rijn P., Vellema P. First outbreak of bluetongue in goats in The Netherlands. Tijdschr Diergeneeskd 2007, 132:786-790.
6. Elbers A.R., Backx A., Mintiens K., Gerbier G., Staubach C., Hendrickx G., et al. Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands. Prev Vet Med 2008, 87:31-40.
7. European Commission, 2008/655/EC. Commission Decision of 24 July 2008 approving the emergency vaccination plans against Bluetongue of certain Member States and fixing the level of the Community's financial contribution for 2007 and 2008. Off J Eur Union, L214/66 (August) 2012.
8. Vitour D., Guillotin J., Sailleau C., Viarouge C., Desprat A., Wolff F., et al. Colostral antibody induced interference of inactivated bluetongue serotype-8 vaccines in calves. Vet Res 2011, 42:18.
9. Hamers C, Blanchet M, Besancon L, Duboeuf M, Goutebroze S, Hudelet P, et al. Efficacy of BTVPUR AlSap® 8 in lambs, in the face of maternally derived antibodies. In: Proceedings of the 15th Epizone Annual Meeting 11-14 April 2011, Arnhem, The Netherlands, pp. 76. Available from: [accessed 06.12.12]. http://www.epizone-eu.net/media/16665/Abstractbook_5th%2520AM_secure.pdf.
10. Hamers C., Galleau S., Chery R., Blanchet M., Besancon L., Cariou C., et al. Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle. Vet Rec 2009, 165:369-373.
11. Morein B., Abusugra I., Blomqvist G. Immunity in neonates. Vet Immunol Immunopathol 2002, 87:207-213.
12. Wackerlin R., Eschbaumer M., Konig P., Hoffmann B., Beer M. Evaluation of humoral response and protective efficacy of three inactivated vaccines against bluetongue virus serotype 8 one year after vaccination of sheep and cattle. Vaccine 2010, 28:4348-4355.
13. Savini G., Monaco F., Citarella R., Calzetta G., Panichi G., Ruiu A., et al. Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows. Vet Ital 2004, 40:664-667.
14. Dagan R., Amir J., Mijalovsky A., Kalmanovitch I., Bar-Yochai A., Thoelen S., et al. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. Pediatr Infect Dis J 2000, 19:1045-1052.
15. Siegrist C.A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21:3406-3412.
16. Oura C.A., Wood J.L., Floyd T., Sanders A.J., Bin-Tarif A., Henstock M., et al. Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine. Vaccine 2010, 28:2749-2753.
17. Surveillance network for Bluetongue. Bluetongue epidemiological situation in EU member states and third countries. Period 1st May 2010-1st July 2011. Available from: [accessed 25.08.12]. http://eubtnet.izs.it/btnet/reports/historical/EpidemReport_2011_1May_01July.pdf.
18. Surveillance network for Bluetongue. Bluetongue epidemiological situation in EU member states and third countries. Period 1st May 2011-13th February 2012. Available from: [accessed 25.08.12]. http://eubtnet.izs.it/btnet/reports/historical/EpidemReport_2012_1May_13February.pdf.